Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Meszaros (Budapest, Hungary), A. Kis (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), P. Horvath (Budapest, Hungary), Z. Lazar (Budapest, Hungary), L. Kunos (Budapest, Hungary), A. Bikov (Budapest, Hungary). Overnight changes in exhaled carbon monoxide levels in obstructive sleep apnoea. 1081

Member's Comments

No comment yet.

Related content which might interest you: Pattern of exhaled volatile organic compounds is altered in children with obstructive sleep apnea Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 The role of inflammatory mediator in exhaled breath condensate of obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004 Spirometry and nocturnal oxygen saturation in patients with obstructive sleep apnoea with and without COPD Source: Eur Respir J 2005; 26: Suppl. 49, 568s Year: 2005 Effect of nasal CPAP on exhaled nitric oxide in patients with obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 Overnight transcutaneous carbon dioxide monitoring in eucapneic patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013 Utility of awake oxygen saturation to identify obstructive sleep apnoea Source: International Congress 2019 – Diagnostic issues in obstructive sleep apnoea Year: 2019 Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Diurnal variation of exhaled nitric oxide in obstructive sleep apnea syndrome and healthy subjects Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 impact of continous positive airway pressure therapy on exhaled nitic oxide in obstructive sleep apnea syndrome Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Peculiarities of nocturnal oxygen saturation in obstructive sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004 Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006 Concentration of exhaled nitric oxide (FENO) in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004 Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003 Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012 Oxydative stress in obstructive sleep apnea: Value of fractional exhaled nitric oxide measurement Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients Source: Annual Congress 2005 - Control of breathing Year: 2005 The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005 Oxydative stress in obstructive sleep apnea (OSA). Exhaled breath condensate (EBC) measurements (H2O2) in the follow-up of patients under CPAP. First results Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007